Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("0268-1315")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1498

  • Page / 60
Export

Selection :

  • and

Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorderMONTGOMERY, Stuart A; LOCKLEAR, Julie C; SVEDSÄTER, Henrik et al.International clinical psychopharmacology. 2014, Vol 29, Num 5, pp 252-262, issn 0268-1315, 11 p.Article

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobiaGOLUBCHIK, Pavel; SEVER, Jonathan; WEIZMAN, Abraham et al.International clinical psychopharmacology. 2014, Vol 29, Num 4, pp 212-215, issn 0268-1315, 4 p.Article

Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparisonFU, Dong-Jing; BOSSIE, Cynthia A; SLIWA, Jennifer K et al.International clinical psychopharmacology. 2014, Vol 29, Num 1, pp 45-55, issn 0268-1315, 11 p.Article

Pharmacotherapy in the treatment of patients with borderline personality disorder: results of a survey among psychiatrists in private practicesKNAPPICH, Moritz; HÖRZ-SAGSTETTER, Susanne; SCHWERTHÖFFER, Dirk et al.International clinical psychopharmacology. 2014, Vol 29, Num 4, pp 224-228, issn 0268-1315, 5 p.Article

Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension studyALAM, Mohammed Y; JACOBSEN, Paula L; YINZHONG CHEN et al.International clinical psychopharmacology. 2014, Vol 29, Num 1, pp 36-44, issn 0268-1315, 9 p.Article

Venlafaxine extended-release treatment of hoarding disorderSAXENA, Sanjaya; SUMNER, Jennifer.International clinical psychopharmacology. 2014, Vol 29, Num 5, pp 266-273, issn 0268-1315, 8 p.Article

Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature?CROPLEY, Vanessa; WOOD, Stephen J; PANTELIS, Christos et al.International clinical psychopharmacology. 2013, Vol 28, issn 0268-1315, S3-S15, SUP1Article

A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorderTOURIAN, Karen; YING WANG; LI, Yoichi et al.International clinical psychopharmacology. 2013, Vol 28, Num 4, pp 206-213, issn 0268-1315, 8 p.Article

Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind studyLIN, Ching-Hua; WANG, Fu-Chiang; LIN, Shih-Chi et al.International clinical psychopharmacology. 2013, Vol 28, Num 5, pp 267-274, issn 0268-1315, 8 p.Article

Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term dataDELL'OSSO, Bernardo; KETTER, Terence A.International clinical psychopharmacology. 2013, Vol 28, Num 6, pp 297-304, issn 0268-1315, 8 p.Article

Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control studyBARRIO, Pablo; BATALLA, Albert; CASTELLVI, Pere et al.International clinical psychopharmacology. 2013, Vol 28, Num 4, pp 164-170, issn 0268-1315, 7 p.Article

No changes in striatal dopamine transporter in antidepressant-treated patients with major depressionWU, Cheng-Kuan; KAO CHIN CHEN; PO SEE CHEN et al.International clinical psychopharmacology. 2013, Vol 28, Num 3, pp 141-144, issn 0268-1315, 4 p.Article

Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's diseaseEDLINGER, Monika; SEPPI, Klaus; FLEISCHHACKER, Wolfgang et al.International clinical psychopharmacology. 2013, Vol 28, Num 4, pp 214-216, issn 0268-1315, 3 p.Article

Assessing the relationship between functional impairment/ recovery and depression severity: a pooled analysisGUICO-PABIA, Christine J; FAYYAD, Rana S; SOARES, Claudio N et al.International clinical psychopharmacology. 2012, Vol 27, Num 1, pp 1-7, issn 0268-1315, 7 p.Article

Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants: a meta-analysisXIAOFENG ZHAO; YINGLIN HUANG; JINGYING LI et al.International clinical psychopharmacology. 2012, Vol 27, Num 6, pp 314-320, issn 0268-1315, 7 p.Article

Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from Quetiapine immediate release to extended releaseDELL'OSSO, Bernardo; ARICI, Chiara; DOBREA, Cristina et al.International clinical psychopharmacology. 2012, Vol 27, Num 6, pp 310-313, issn 0268-1315, 4 p.Article

Deep brain stimulation increases impulsivity in two patients with obsessive-compulsive disorderLUIGJES, Judy; MANTIONE, Mariska; DEN BRINK, Wim Van et al.International clinical psychopharmacology. 2011, Vol 26, Num 6, pp 338-340, issn 0268-1315, 3 p.Article

Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic reviewSAMUEL, Miny; ZIMOVETZ, Evelina A; GABRIEL, Zahava et al.International clinical psychopharmacology. 2011, Vol 26, Num 2, pp 63-68, issn 0268-1315, 6 p.Article

Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trialKATZMAN, Martin A; BRAWMAN-MINTZER, Olga; REYES, Efren B et al.International clinical psychopharmacology. 2011, Vol 26, Num 1, pp 11-24, issn 0268-1315, 14 p.Article

Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysisWAINSTEIN, Laura; VICTORRI-VIGNEAU, Caroline; SEBILLE, Véronique et al.International clinical psychopharmacology. 2011, Vol 26, Num 1, pp 54-62, issn 0268-1315, 9 p.Article

Relationship between African―American or Caucasian origin and outcomes in the olanzapine treatment of acute mania: a pooled analysis of three adult studies conducted in the United States of AmericaDEGENHARDT, Elisabeth K; TAMAYO, Jorge M; JAMAL, Hassan H et al.International clinical psychopharmacology. 2011, Vol 26, Num 3, pp 141-145, issn 0268-1315, 5 p.Article

Relationship between insulin resistance and C-reactive protein in a patient population treated with second generation antipsychotic medicationsKIM, Sun H; REAVEN, Gerald; LINDLEY, Steven et al.International clinical psychopharmacology. 2011, Vol 26, Num 1, pp 43-47, issn 0268-1315, 5 p.Article

A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelinesPASCUAL, Juan C; MARTIN-BLANCO, Ana; SOLER, Joaquim et al.International clinical psychopharmacology. 2010, Vol 25, Num 6, pp 349-355, issn 0268-1315, 7 p.Article

Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidoneCANUSO, Carla M; GRINSPAN, Augusto; KALALI, Amir et al.International clinical psychopharmacology. 2010, Vol 25, Num 3, pp 155-164, issn 0268-1315, 10 p.Article

Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementiaTRIFIRO, Gianluca; SINI, Giovanna; SAMANI, Fabio et al.International clinical psychopharmacology. 2010, Vol 25, Num 1, pp 22-28, issn 0268-1315, 7 p.Article

  • Page / 60